The companies that almost listed in 2024 are not listing in 2026. The deferral patterns explain why.

Through 2024, a meaningful pipeline of Malaysian companies were in advanced preparation for KLSE main market or ACE market listings. Bankers were appointed. Auditors were engaged. Draft prospectuses were circulating. Roadshow plans were under development. Two years later, a significant share of those companies are not listed and are not in the immediate pipeline. The deferrals tell a more useful story than the actual listings would have.

The deferred companies fall into three categories.

The first category is the companies whose financials no longer support the original valuation thesis. The 2024 listing pitch was built around three years of strong revenue growth and improving margins. Through 2025, growth slowed and margins compressed. The company would still list, in theory, but at a substantially lower valuation than the pre-IPO investors and existing shareholders are willing to accept. The deferral is essentially a private decision to wait for better numbers, even though waiting carries its own risks.

The second category is the companies whose business model has shifted enough that the original prospectus narrative no longer accurately describes what the company does. A pure e-commerce operator that became a logistics company. A consumer brand that became a services company. A retail operator that became a franchise operator. The shifts are usually positive for the underlying economics but require the prospectus to be substantially rewritten and the new narrative to be re-tested with institutional investors. That work takes time and the management team often deprioritises it while the operational business is doing well.

The third category is the companies whose key shareholders no longer agree on the listing path. The original 2024 plan assumed alignment among founders, early investors, and growth-stage VCs on timing, valuation, and post-listing strategy. By 2025 or 2026, that alignment has broken down. One group wants liquidity now at a lower valuation. Another wants to hold for a higher valuation later. A third wants to abandon the listing entirely in favour of a strategic exit. The deferral is essentially a negotiation that has not yet resolved.

What this means for the regional ecosystem is straightforward. The 2024 listing pipeline overstated the actual conversion rate. Investors who were modelling deal flow based on the announcement pipeline overestimated the volume of capital that would be raised. Bankers who allocated resources to the pipeline have spent two years on deals that did not close. The cumulative effect is that the next pipeline announcement should be discounted more heavily than the 2024 announcements were.

The companies that did list through 2025 and into 2026 are not necessarily the best companies in the original pipeline. They are the companies whose specific deferral risks did not materialise. The market should not infer too much from listing volume in either direction. The actual indicator of regional capital market health is the conversion rate from advanced preparation to closed listing, which is a number nobody publishes and which is currently substantially lower than the pipeline announcements would suggest.